pyruvaldehyde has been researched along with transforming growth factor alpha in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asai, K; Imaeda, K; Joh, T; Kato, T; Kimura, R; Okayama, N; Okouchi, M | 1 |
1 other study(ies) available for pyruvaldehyde and transforming growth factor alpha
Article | Year |
---|---|
Epidermal growth factor receptor transactivation is necessary for glucagon-like peptide-1 to protect PC12 cells from apoptosis.
Topics: Animals; Apoptosis; Brain Diseases, Metabolic; Cytoprotection; Diabetes Complications; ErbB Receptors; Gene Expression Regulation, Neoplastic; Glucagon-Like Peptide 1; Heparin-binding EGF-like Growth Factor; Intercellular Signaling Peptides and Proteins; Neurons; Neuroprotective Agents; PC12 Cells; Phosphorylation; Protein Kinases; Pyruvaldehyde; Rats; Signal Transduction; Transcriptional Activation; Transforming Growth Factor alpha | 2013 |